BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17486057)

  • 1. p53 and SCFFbw7 cooperatively restrain cyclin E-associated genome instability.
    Minella AC; Grim JE; Welcker M; Clurman BE
    Oncogene; 2007 Oct; 26(48):6948-53. PubMed ID: 17486057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
    Xu Y; Sengupta T; Kukreja L; Minella AC
    J Biol Chem; 2010 Nov; 285(45):34439-46. PubMed ID: 20826802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras activity regulates cyclin E degradation by the Fbw7 pathway.
    Minella AC; Welcker M; Clurman BE
    Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9649-54. PubMed ID: 15980150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of APC(Cdh1) E3 ligase activity by the Fbw7/cyclin E signaling axis contributes to the tumor suppressor function of Fbw7.
    Lau AW; Inuzuka H; Fukushima H; Wan L; Liu P; Gao D; Sun Y; Wei W
    Cell Res; 2013 Jul; 23(7):947-61. PubMed ID: 23670162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBW7 regulates DNA interstrand cross-link repair by modulating FAAP20 degradation.
    Wang J; Jo U; Joo SY; Kim H
    Oncotarget; 2016 Jun; 7(24):35724-35740. PubMed ID: 27232758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fbw7 isoform interaction contributes to cyclin E proteolysis.
    Zhang W; Koepp DM
    Mol Cancer Res; 2006 Dec; 4(12):935-43. PubMed ID: 17189384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium ascorbate inhibits growth via the induction of cell cycle arrest and apoptosis in human malignant melanoma A375.S2 cells.
    Lin SY; Lai WW; Chou CC; Kuo HM; Li TM; Chung JG; Yang JH
    Melanoma Res; 2006 Dec; 16(6):509-19. PubMed ID: 17119452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.
    Vaziri H; West MD; Allsopp RC; Davison TS; Wu YS; Arrowsmith CH; Poirier GG; Benchimol S
    EMBO J; 1997 Oct; 16(19):6018-33. PubMed ID: 9312059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy.
    Finkin S; Aylon Y; Anzi S; Oren M; Shaulian E
    Oncogene; 2008 Jul; 27(32):4411-21. PubMed ID: 18391985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase.
    Ye X; Nalepa G; Welcker M; Kessler BM; Spooner E; Qin J; Elledge SJ; Clurman BE; Harper JW
    J Biol Chem; 2004 Nov; 279(48):50110-9. PubMed ID: 15364936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.
    Caldon CE; Sergio CM; Sutherland RL; Musgrove EA
    Cell Cycle; 2013 Feb; 12(4):596-605. PubMed ID: 23324394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of cyclin E meets dysfunction in p53: closing the escape hatch on breast cancer.
    Barton MC; Akli S; Keyomarsi K
    J Cell Physiol; 2006 Dec; 209(3):686-94. PubMed ID: 17001684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model for cyclin E-dependent genetic instability and tumorigenesis.
    Loeb KR; Kostner H; Firpo E; Norwood T; D Tsuchiya K; Clurman BE; Roberts JM
    Cancer Cell; 2005 Jul; 8(1):35-47. PubMed ID: 16023597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases.
    Hao B; Oehlmann S; Sowa ME; Harper JW; Pavletich NP
    Mol Cell; 2007 Apr; 26(1):131-43. PubMed ID: 17434132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.
    Kawamura K; Izumi H; Ma Z; Ikeda R; Moriyama M; Tanaka T; Nojima T; Levin LS; Fujikawa-Yamamoto K; Suzuki K; Fukasawa K
    Cancer Res; 2004 Jul; 64(14):4800-9. PubMed ID: 15256449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.
    Lindahl T; Landberg G; Ahlgren J; Nordgren H; Norberg T; Klaar S; Holmberg L; Bergh J
    Carcinogenesis; 2004 Mar; 25(3):375-80. PubMed ID: 14633656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells.
    Willmarth NE; Albertson DG; Ethier SP
    Breast Cancer Res; 2004; 6(5):R531-9. PubMed ID: 15318934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
    Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.